4-(Butylthio)-2,5-dimethoxybenzaldehyd | 648956-96-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(Butylthio)-2,5-dimethoxybenzaldehyd
• 英文别名: 2,5-dimethoxy-4-n-butylthiobenzaldehyde；Benzaldehyde, 4-(butylthio)-2,5-dimethoxy-；4-butylsulfanyl-2,5-dimethoxybenzaldehyde
• CAS: 648956-96-1
• 化学式: C₁₃H₁₈O₃S
• 分子量: 254.35
• InChiKey: KRPGTVMKAWMNLA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  17
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  60.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4-(Butylthio)-2,5-dimethoxybenzaldehyd 在 lithium aluminium tetrahydride 、 ammonium acetate 、 溶剂黄146 作用下， 以 四氢呋喃 、 1,2-二氯乙烷 为溶剂， 反应 19.25h， 生成 1-(4-(butylthio)-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)propan-2-amine
  参考文献：
  名称：

  [EN] PHENALKYLAMINES AND METHODS OF MAKING AND USING THE SAME
  [FR] PHÉNALKYLAMINES ET LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION

  摘要：

  本公开提供了苯基烷胺化合物及其在治疗医学疾病（如精神科疾病和障碍）中的应用。提供了制备各种苯基烷胺化合物的制药组合物和方法。

  公开号：

  WO2022192781A1
• 作为产物：
  描述：

  2,5-二甲氧基苯磺酰氯 在 盐酸 、 氢氧化钾 、 锌 、 三氯氧磷 作用下， 以 甲醇 为溶剂， 反应 1.75h， 生成 4-(Butylthio)-2,5-dimethoxybenzaldehyd
  参考文献：
  名称：

  Sulfur-Substituted α-Alkyl Phenethylamines as Selective and Reversible MAO-A Inhibitors:  Biological Activities, CoMFA Analysis, and Active Site Modeling

  摘要：

  A series of phenethylamine derivatives with various ring substituents and with or without N-methyl and/or C-alpha methyl or ethyl groups was synthesized and assayed for their ability reversibly to inhibit monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B). Several compounds. showed potent and selective MAO-A inhibitory activity (IC50 in the submicromolar range) but none showed appreciable activity toward MAO-B. A three-dimensional quantitative structure-activity relationship study for MAO-A inhibition was performed on the series using comparative molecular field analysis (CoMFA). The resulting model gave a cross-validated q(2) of 0.72 and showed that in this series of compounds steric properties of the substituents were more important than electrostatic effects. Molecular modeling based on the recently published crystal structure of inhibitor-bound MAO-A provided detailed evidence for specific interactions of the ligands with the enzyme, supported by previous references and consistent with results from the CoMFA. On the basis of these results, structural determinants for selectivity of substituted amphetamines for MAO-A are discussed.

  DOI：

  10.1021/jm0493109

文献信息

• Synthese von neuen (Phenylalkyl)aminen zur Untersuchung von Struktur–Aktivitätsbeziehungen. Mitteilung 2
  作者：Daniel Trachsel

  DOI：10.1002/hlca.200390210

  日期：2003.7

  Synthesis of Novel (Phenylalkyl)amines for the Investigation of Structure–Activity Relationships. Part 21). 4-Thio-Substituted [2-(2,5-Dimethoxyphenyl)ethyl]amines (=2,5-Dimethoxybenzeneethanamines)

  新型（苯基烷基）胺的合成，用于研究结构与活性之间的关系。第2部分1）。4-硫代取代的[2-（2,5-二甲氧基苯基）乙基]胺（= 2,5-二甲氧基苯乙胺）
• Sulfur-Substituted α-Alkyl Phenethylamines as Selective and Reversible MAO-A Inhibitors:  Biological Activities, CoMFA Analysis, and Active Site Modeling
  作者：Alejandra Gallardo-Godoy、Angélica Fierro、Thomas H. McLean、Mariano Castillo、Bruce K. Cassels、Miguel Reyes-Parada、David E. Nichols

  DOI：10.1021/jm0493109

  日期：2005.4.1

  A series of phenethylamine derivatives with various ring substituents and with or without N-methyl and/or C-alpha methyl or ethyl groups was synthesized and assayed for their ability reversibly to inhibit monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B). Several compounds. showed potent and selective MAO-A inhibitory activity (IC50 in the submicromolar range) but none showed appreciable activity toward MAO-B. A three-dimensional quantitative structure-activity relationship study for MAO-A inhibition was performed on the series using comparative molecular field analysis (CoMFA). The resulting model gave a cross-validated q(2) of 0.72 and showed that in this series of compounds steric properties of the substituents were more important than electrostatic effects. Molecular modeling based on the recently published crystal structure of inhibitor-bound MAO-A provided detailed evidence for specific interactions of the ligands with the enzyme, supported by previous references and consistent with results from the CoMFA. On the basis of these results, structural determinants for selectivity of substituted amphetamines for MAO-A are discussed.
• [EN] PHENALKYLAMINES AND METHODS OF MAKING AND USING THE SAME<br/>[FR] PHÉNALKYLAMINES ET LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION
  申请人：GILGAMESH PHARMACEUTICALS INC

  公开号：WO2022192781A1

  公开（公告）日：2022-09-15

  The present disclosure provides phenalkylamine compounds and their use in treating medical disorders, such as psychiatric diseases and disorders. Pharmaceutical compositions and methods of making various phenalkylamine compounds are provided.

  本公开提供了苯基烷胺化合物及其在治疗医学疾病（如精神科疾病和障碍）中的应用。提供了制备各种苯基烷胺化合物的制药组合物和方法。